Cover Image


View/Hide Left Panel

Where Do We Go From Here?

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 191
Medicare: New Directions in Quality Assurance PART X Where Do We Go From Here?

OCR for page 191
Medicare: New Directions in Quality Assurance This page in the original is blank.

OCR for page 191
Medicare: New Directions in Quality Assurance Where Do We Go From Here? Introduction Molla S. Donaldson, Jo Harris-Wehling, and Kathleen N. Lohr The final part of the proceedings asks about the next steps in implementing the recommendations of the Institute of Medicine report. In closing the conference, two presenters, Ceylon S. Lewis, Jr. and Jerome H. Grossman, provided thoughtful and vigorous support for the report. Dr. Lewis, who is in the private practice of internal medicine in Tulsa, Oklahoma, also serves on the Board of the Joint Commission on Accreditation of Healthcare Organizations. In his commentary, he reviews major mechanisms in place in the private and public sector to maintain high quality of care such as medical education, board certification, and hospital accreditation. He also comments on the IOM's 10 recommendations and how these might be accomplished by joint efforts of the public and private sectors. Dr. Grossman is the Chairman and Chief Executive Officer of the New England Medical Center in Boston. He sees the strategy as a "mid-course correction" in the Medicare program, and the maturation of outcomes and health status measures and the involvement of patients in their care as critical to making the shift to a broader definition of quality and outcome. He calls for a long-term investment in quality to develop a national strategy beyond Medicare.